Randomized Controlled Trial of urinE chemiStry Guided aCute heArt faiLure treATmEnt (ESCALATE)
A phase 2 trial registered on ClinicalTrials.gov. The registry status is active, not recruiting. It plans to enroll 474 participants.
Also called NCT04481919
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase
- Phase 2
- Enrolled
- 474 participants
- Registry
-
NCT04481919
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (anticipated)
- Countries
- United States
- Registry status
- Active, not recruiting
Technical summary
Registry record NCT04481919. Randomized; quadruple masking; primary purpose treatment. Start 2022-05-01 (actual); primary completion 2025-11-22 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Randomized Controlled Trial of urinE chemiStry Guided aCute heArt faiLure treATmEnt (ESCALATE)
- Acronym
- ESCALATE
- Condition
- Heart Failure
- Condition
- Acute Heart Failure
- Intervention (Drug)
- Protocolized diuretic therapy
- Lead sponsor
- Vanderbilt University Medical Center
Record details
- Record id
cardio:ct-nct04481919- Content hash
52d05271d7e6ede16721d195e2e202025c5f09073dc4defab51a78713465ae45